 |
[AC3-yCD2(V)] and Flucytosine (5-FC XR) |
|---|---|
| Trade Name | |
| Orphan Indication | Glioblastoma multiforme |
| USA Market Approval | USA |
| USA Designation Date | 2011-01-12 00:00:00 |
| Sponsor | Tocagen, Inc.;3030 Bunker Hill St.;San Diego, California, 92109 |
| |
[AC3-yCD2(V)] and Flucytosine (5-FC XR) |
|---|---|
| Trade Name | |
| Orphan Indication | Glioblastoma multiforme |
| USA Market Approval | USA |
| USA Designation Date | 2011-01-12 00:00:00 |
| Sponsor | Tocagen, Inc.;3030 Bunker Hill St.;San Diego, California, 92109 |